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Background-—Atrial ﬁbrillation (AF) prevalence is increasing, and body mass index (BMI) is a risk factor for AF. However, sex
differences in the impact of BMI on AF risk have not been fully elucidated.
Methods and Results-—Data from the fourth survey (1994–1995) of the Tromsø Study (Norway) were used to investigate the
association of single-measurement BMI on future AF risk. To analyze the inﬂuence of BMI changes on AF risk, data from individuals
who attended the third and fourth study surveys were used. AF diagnosis was derived from record linkage and end point
adjudication. Cox regression analysis was conducted using fractional polynomials of BMI and BMI change with models adjusted for
age, baseline BMI (change analyses), risk factors, comorbidities, and antihypertensive medications. Data were available for 24 799
individuals from the fourth survey (mean age, 45.514.2 years; 52.9% women). Over 15.75.5 years, 811 women (6.2%) and 918
men (7.9%) developed AF. In men, lower BMI decreased AF risk and higher BMI increased risk (hazard ratios [95% conﬁdence
intervals] for BMI 18 or 40 kg/m2 compared with 23 kg/m2 were 0.75 [0.70–0.81] and 4.42 [3.00–6.53], respectively). The same
pattern was identiﬁed in women. Two surveys were attended by 14 652 individuals. In men and women, a decrease in BMI over
time was associated with decreased AF risk and an increase in BMI was associated with increased AF risk.
Conclusions-—Within a population cohort, BMI was positively associated with AF risk. Change in BMI over time inﬂuenced AF risk
in both men and women. ( J Am Heart Assoc. 2018;7:e008414. DOI: 10.1161/JAHA.117.008414.)
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A trial ﬁbrillation (AF) is the most common cardiac rhythmdisturbance observed and treated in clinical practice. In
2010, an estimated 5 million incident cases of AF were
diagnosed globally, while AF is prevalent in 2% to 3% of the
world’s population overall.1,2 Prevalence of AF is increasing in
parallel to population ageing and improved survival from other
clinical conditions that increase the likelihood of AF develop-
ment. Furthermore, little progress has been made in reducing
major signiﬁcant risk factors for AF, such as excess body
weight.2 Multiple complications are the direct result of AF,
including thromboembolic events (notably stroke), heart
failure, reduced quality of life, and even death.3,4
Over recent decades, the global prevalence of overweight
and obesity has increased rapidly to epidemic proportions.5 In
northern Norway, population trends in mean body mass index
(BMI) and the prevalence of obesity have demonstrated a
steady increase over time, particularly in younger age
groups.6 Overweight and obesity are signiﬁcant risk factors
From the Pre-Clinical Disease and Prevention, Baker Heart and Diabetes Institute, Melbourne, Australia (J.B., M.-L.L.); School of Public Health and Preventive Medicine,
Monash University, Melbourne, Australia (J.B.); Department of Community Medicine (M.-L.L., T.W., B.M., I.N., S.T., E.S.), Clinical Medicine (H.S., E.B.M.), and Health and
Care Sciences (L.A.H.), School of Sport Sciences (B.M.), UiT The Arctic University of Norway, Tromsø, Norway; Department of Clinical Medicine, University of Oslo,
Norway (H.S.); Department of Cardiology, Akershus University Hospital, Lørenskog, Norway (H.S.); and Department of Neurology, University Hospital of North Norway,
Tromsø, Norway (E.B.M.).
An accompanying Table S1 is available at http://jaha.ahajournals.org/content/7/9/e008414/DC1/embed/inline-supplementary-material-1.pdf
Correspondence to: Jocasta Ball, BBiomedSci(Hons), PhD, Baker Heart and Diabetes Institute, 75 Commercial Rd, Melbourne, Victoria 3004, Australia. E-mail:
Jocasta.Ball@baker.edu.au
Received December 19, 2017; accepted March 26, 2018.
ª 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons
Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
DOI: 10.1161/JAHA.117.008414 Journal of the American Heart Association 1
ORIGINAL RESEARCH
 by guest on June 21, 2018
http://jaha.ahajournals.org/
D
ow
nloaded from
 
for multiple chronic diseases, including cardiovascular disease
(CVD), diabetes mellitus, cancer, and musculoskeletal disor-
ders. Excess body weight causes 3 million deaths around
the world every year.7 Current epidemiological trends in
overweight and obesity are major public health challenges,
particularly in relation to reduced quality of life and increased
health costs.8
It is already established that overweight and obesity are
associated with an increased risk of AF, although lack of
consensus about patterns of association exists.9,10 Some
have suggested a J-shaped dose-response relationship
between BMI and AF11,12; however, others have found a
linear association.13–19 A recent systematic review and dose-
response meta-analysis of prospective studies demonstrated
a nonlinear association between BMI and risk of AF, with a
stronger association at higher BMI levels and a 28% increase
in the relative risk of AF for every 5 kg/m2 increase in BMI
identiﬁed.20 Increased risk was also demonstrated with
relatively higher BMI, even within the normal BMI range.20
However, not all included studies took sex into consideration
during analysis. The incidence of AF differs between men and
women (it is up to 2 times higher in men21) because of the
prevalence of major risk factors for AF, including hyperten-
sion, diabetes mellitus, coronary artery disease, and heart
failure, also differing between the sexes.21 Given that excess
body weight is a modiﬁable risk factor and AF differs
causatively in women versus men,22 it is important to
understand if differences in the inﬂuence of BMI exist
between men and women. We, therefore, aimed to investigate
the impact of BMI on longer-term risk of AF and the impact of
change in BMI over time in men and women using the
longitudinal Tromsø Study.
Methods
The data, analytic methods, and study materials will not be
made available to other researchers for purposes of repro-
ducing the results or replicating the procedure.
Study Setting and Participants
The Tromsø Study is a population-based longitudinal study
involving CVD epidemiological screening, the details of which
have been described previously.23,24 In brief, total birth
cohorts in addition to random population samples from the
municipality of Tromsø, northern Norway, were invited to
participate in ≥1 of 7 health surveys conducted from 1974 to
2016. For the current study, data were used from participants
who attended the third (1986–1987) and fourth (1994–1995)
surveys. Each study visit was conducted by trained personnel
and according to the same core protocol. Data collection
consisted of questionnaires, interviews, physical measure-
ments, biological sample collection, and clinical
examinations.23,24 Data from individuals who had missing
information on BMI, who emigrated before the start of follow-
up, or who developed AF before the start of follow-up were
excluded from the current analyses. Individuals for whom
outcome data were insufﬁcient to conﬁrm or deny a diagnosis
of AF were also excluded from analyses. Figure 1A demon-
strates the total cohort who attended the fourth Tromsø Study
survey, consisting of 24 799 individuals (11 673 men and
13 126 women; mean age, 45.514.2 years) included in the
analysis of BMI inﬂuence on risk of future AF. The same data
for the cohort included in analyses of individual change in BMI
over time and inﬂuence on future AF (n=14 652) are also
included in Figure 1B. For this change analysis, individuals
who attended the third and fourth Tromsø Study surveys were
included (7158 men and 7494 women).
Ethical considerations
The Tromsø Study was approved by the Data Inspectorate and
by the Regional Committee for Medical Research Ethics,
North Norway, and was performed in accordance with the
ethical standards laid down in the Declaration of Helsinki. All
Clinical Perspective
What Is New?
• Data from the Tromsø Study showed that in men and
women, lower body mass index (BMI) was associated with a
decreased risk of future atrial ﬁbrillation (AF) development
and increased BMI was associated with increased AF
risk.
• In men and women, a decrease in BMI over time was
associated with a decreased risk of future AF and an
increase in BMI over the same time was associated with
increased AF risk.
• Sex differences were identiﬁed in the risk of AF develop-
ment, with associations found to be stronger in men than in
women for both single-measurement BMI and BMI change
over time.
What Are the Clinical Implications?
• Higher BMI potentially has a greater inﬂuence on future AF
development in men than in women.
• Identifying sex-speciﬁc differences in the inﬂuence of BMI
on incident AF will assist in the primary prevention of AF and
has the potential to contribute to sex-speciﬁc preventive
strategies.
• Interventions to decrease BMI should be encouraged for
men and women with higher BMI above that considered
normal.
• Even modest reductions in population BMI are likely to have
a signiﬁcant effect on the public health burden of AF.
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participants from the fourth survey provided informed
consent, and living participants from prior surveys were
provided the opportunity to withdraw from the study.
Data Collection
Cohort proﬁling
Use of antihypertensive medication (yes/no), leisure time
physical activity (inactive/low activity/moderate activity/high
activity), current daily smoking (yes/no), and medical history
(myocardial infarction, angina pectoris, stroke, diabetes
mellitus; yes/no) were extracted from the Tromsø Study
questionnaire. Physical activity levels were determined by the
number of self-reported hours per week of light activity and
hard activity. Questions on leisure time physical activity were
different in the fourth survey from those in the prior survey;
therefore, answers were recoded to correspond to the
categories used in the third survey.25
Figure 1. Study ﬂow chart of included participants for analyses of single-measurement body mass index
(BMI) (A) and individual change in BMI over time (B), in the Tromsø Study (1986–1995). AF indicates atrial
ﬁbrillation.
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Nonfasting serum total cholesterol, high-density lipoprotein
(HDL) cholesterol, and triglyceride levels (mmol/L) were
analyzed by the Department of Laboratory Medicine, University
Hospital of North Norway (Tromsø). Blood pressure was
measured using an oscillometric digital automatic device
(Dinamap Vital Signs Monitor 1846; Critikon Inc, Tampa, FL)
with the mean of the last 2 of 3 recordings used. Weight and
height were measured with only light clothing on and no shoes
and were used to calculate BMI (kilograms per meter squared
[kg/m2]). The World Health Organization international classi-
ﬁcation of BMI groups (including additional cutoffs for public
health action) was used to categorize the participant cohort.26
Participants were classiﬁed as being underweight (BMI,
<18.50 kg/m2), normal weight (BMI, 18.50–22.99 kg/m2; or
BMI, 23.00–24.99 kg/m2), overweight (BMI, 25.00–27.49 kg/
m2; or BMI, 27.50–29.99 kg/m2), or obese (class I: BMI,
30.00–34.99 kg/m2; or class II/III: BMI, ≥35.00 kg/m2).26
Follow-up and incident AF detection
Follow-up began from the date of the last Tromsø Study
survey examination attended (1994–1995) until the date of
ﬁrst documented AF, date of censorship because of migration
or death (identiﬁed through the Population Register of
Norway), or the end of follow-up at December 31, 2013,
whichever came ﬁrst. Incident cases of AF documented on
ECG were derived from hospital record (diagnosis registry
including outpatient clinic) linkage with the University Hospital
of North Norway (the only hospital within a radius of 250 km)
and to the National Causes of Death Registry using the
following diagnostic codes: International Classiﬁcation of
Diseases, Ninth Revision (ICD-9) codes 427.0 to 427.99 and
International Classiﬁcation of Diseases, Tenth Revision (ICD-
10) codes I47 and I48. Norway has a unique personal
identiﬁcation system that makes exact matching in medical
registers possible. For participants with diagnoses of cere-
brovascular or cardiovascular events, hospital records were
also reviewed for further AF events. Adjudication of all AF
events was conducted by an end point committee.27 AF
subtype was categorized into any, paroxysmal/persistent, or
permanent.28 According to management guidelines, AF is
classiﬁed as being paroxysmal (lasting ≤7 days and self-
terminating), persistent (lasting >7 days, usually requiring
termination with cardioversion and/or medication), or per-
manent (for which a rhythm control strategy is not pursued).28
Within the current study, 49.6% of men and 49.5% of women
developed paroxysmal or persistent AF, and 45.9% of men and
43.7% of women developed permanent AF during follow-up.
The pattern of AF was unknown in 4.6% of men and 6.9% of
women. AF occurring during the last 7 days of life, postop-
erative AF occurring within 28 days after surgery, AF related
to myocardial infarction or within 28 days after myocardial
infarction, and AF related to other acute cardiac events (eg,
acute heart failure or pulmonary edema) or within 28 days
after an event were classiﬁed as noncases.
Statistical Analyses
A signiﬁcant interaction between single-measurement BMI
and sex was identiﬁed (P=0.008); therefore, all analyses were
stratiﬁed by sex. No interaction was found between BMI and
age in women, but an interaction was found in men (P=0.025).
No interaction between BMI change and baseline BMI, while
adjusting for baseline age, was identiﬁed in either men or
women. Descriptive data are presented as meanSD for
continuous variables or as number and proportion (%) for
categorical variables. Between-group comparisons were con-
ducted with linear regression, logistic regression, linear mixed
models, or generalized estimating equations, where appropri-
ate, and all models were adjusted for age. All data were
analyzed and forest plots generated using Statistical Analysis
Software, version 9.4 (SAS Institute Inc, Cary, NC). P<0.05 (2-
sided) was considered statistically signiﬁcant.
Analysis of single-measurement BMI on risk of future
AF
Cox proportional hazard regression analysis was conducted
(with calculation of hazard ratios [HRs] and 95% conﬁdence
intervals [CIs]) to assess the association of single-measure-
ment BMI on the risk of future AF, with AF as the dependent
variable, fractional polynomials of BMI as the main predictor,
and fractional polynomials of age as a covariate. A BMI of
23.0 kg/m2 was used as the reference. The model was
additionally adjusted for systolic blood pressure; total
cholesterol, HDL cholesterol, and triglyceride levels; current
daily smoking; physical activity levels; CVD (myocardial
infarction, angina, and stroke); concurrent diabetes mellitus;
and current antihypertensive medications. Stratiﬁcation of
results by age (<65 versus ≥65 years) was conducted for men
because of the demonstrated interaction between BMI and
age. Sensitivity analyses were conducted with the systematic
removal of potential mediating factors (comorbidities, biomed-
ical risk factors, and health-related behaviors) for the
association between BMI and incident AF. Sensitivity analyses
were also conducted to investigate the impact of AF type
(paroxysmal/persistent versus permanent) on the association
of single-measurement BMI on the future risk of AF.
Analysis of individual 10-year change in BMI on risk of
future AF
Individual change in BMIwas estimated as the slope of the linear
regression model, with BMI measured in the third and fourth
Tromsø Study surveys as the dependent variable and year of
examination as the predictor. Cox proportional hazard regres-
sion analysis was conducted (with calculation of HRs and 95%
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Table 1. Baseline Characteristics of 11 673 Men and 13 126 Women According to BMI Groups: The Tromsø Study, 1994 to 1995
Characteristics
BMI, kg/m2
P Value
Underweight Normal Weight Overweight Obese
<18.50 18.50–22.99 23.00–24.99 25.00–27.49 27.50–29.99 30.00–34.99 ≥35.00
Men
No. 62 2385 2973 3406 1775 940 132
Age, mean (SD), y 50.9 (17.7) 42.5 (13.8) 43.6 (13.2) 46.2 (13.5) 47.7 (13.3) 47.6 (13.2) 46.4 (13.5) <0.001
Systolic blood pressure,
mean (SD), mm Hg
128.5 (16.7) 129.7 (15.0) 131.9 (15.1) 134.3 (16.1) 138.0 (17.4) 139.1 (17.6) 142.4 (19.5) <0.001
Total cholesterol, mean (SD), mmol/L 5.43 (1.17) 5.67 (1.18) 5.91 (1.18) 6.13 (1.19) 6.29 (1.20) 6.28 (1.13) 6.40 (1.16) <0.001
HDL cholesterol, mean (SD), mmol/L 1.59 (0.36) 1.46 (0.37) 1.39 (0.34) 1.32 (0.34) 1.24 (0.31) 1.18 (0.30) 1.08 (0.23) <0.001
Triglycerides, mean (SD), mmol/L 1.12 (0.54) 1.31 (0.76) 1.53 (0.89) 1.86 (1.23) 2.20 (1.30) 2.53 (1.58) 2.90 (1.56) <0.001
Physical activity, n (%)
Inactive 11 (15.3) 195 (8.4) 195 (6.6) 224 (6.2) 168 (8.8) 105 (10.4) 17 (12.5) <0.001
Low activity 23 (37.7) 860 (36.1) 1086 (36.7) 1367 (40.6) 768 (44.1) 410 (44.4) 59 (45.9) <0.001
Moderate activity 26 (41.3) 1059 (45.0) 1338 (45.6) 1469 (43.3) 692 (39.2) 362 (38.6) 48 (37.1) <0.001
High activity 2 (3.4) 252 (9.8) 325 (10.4) 319 (9.4) 124 (7.2) 53 (5.8) 5 (3.8) <0.001
Current smoking, n (%) 44 (71.8) 1181 (49.2) 1106 (37.0) 1157 (34.1) 570 (32.5) 295 (31.7) 35 (26.7) <0.001
History of myocardial infarction,
n (%)
0 (0.0) 39 (0.8) 63 (1.1) 111 (1.4) 80 (1.8) 53 (2.4) 7 (2.5) <0.001
History of angina pectoris, n (%) 1 (0.3) 45 (0.8) 83 (1.3) 126 (1.4) 102 (2.1) 65 (2.7) 11 (3.6) <0.001
History of stroke, n (%) 4 (2.2) 22 (0.6) 27 (0.6) 38 (0.6) 28 (0.8) 21 (1.1) 1 (0.4) 0.040
Diabetes mellitus, n (%) 0 (0.0) 17 (0.5) 27 (0.6) 31 (0.5) 32 (1.0) 30 (1.7) 8 (3.7) <0.001
Antihypertensive medications,
n (%)
3 (1.5) 53 (1.4) 90 (1.9) 176 (2.8) 135 (4.0) 106 (6.4) 22 (11.0) <0.001
Women
No. 269 4901 2812 2415 1314 1126 289
Age, mean (SD), y 42.3 (15.5) 41.4 (12.8) 45.3 (14.0) 48.6 (14.8) 51.5 (15.8) 53.0 (15.3) 52.5 (15.3) <0.001
Systolic blood pressure,
mean (SD), mm Hg
122.6 (17.1) 123.9 (16.5) 126.2 (19.2) 128.9 (21.0) 133.4 (23.2) 137.3 (23.4) 142.7 (24.2) <0.001
Total cholesterol, mean (SD), mmol/L 5.70 (1.21) 5.75 (1.24) 6.00 (1.32) 6.17 (1.38) 6.25 (1.38) 6.36 (1.32) 6.31 (1.37) <0.001
HDL cholesterol, mean (SD), mmol/L 1.73 (0.43) 1.73 (0.40) 1.66 (0.40) 1.61 (0.40) 1.54 (0.40) 1.45 (0.36) 1.41 (0.37) <0.001
Triglycerides, mean (SD), mmol/L 1.06 (0.54) 1.07 (0.54) 1.25 (0.73) 1.42 (0.89) 1.65 (1.03) 1.87 (1.14) 1.92 (1.03) <0.001
Physical activity, n (%)
Inactive 31 (11.0) 333 (6.9) 212 (6.4) 211 (6.5) 150 (7.6) 173 (10.1) 58 (13.9) <0.001
Low activity 105 (39.5) 1983 (40.6) 1167 (42.0) 1045 (44.0) 623 (48.3) 523 (47.7) 139 (49.2) <0.001
Moderate activity 121 (45.0) 2272 (45.9) 1286 (46.3) 1047 (44.7) 497 (39.7) 392 (37.1) 80 (29.5) <0.001
High activity 8 (2.6) 266 (4.8) 118 (4.0) 85 (3.7) 30 (2.5) 21 (2.2) 8 (3.2) <0.001
Current smoking, n (%) 154 (56.5) 2128 (42.0) 1026 (36.5) 787 (33.6) 383 (31.0) 302 (29.1) 70 (26.1) <0.001
History of myocardial infarction, n (%) 4 (0.6) 21 (0.2) 20 (0.3) 31 (0.4) 28 (0.5) 25 (0.5) 5 (0.4) 0.132
History of angina pectoris, n (%) 5 (0.5) 53 (0.4) 55 (0.5) 82 (0.7) 75 (0.9) 63 (0.9) 22 (1.3) <0.001
History of stroke, n (%) 2 (0.4) 34 (0.5) 23 (0.5) 20 (0.4) 15 (0.4) 22 (0.7) 7 (0.9) 0.361
Diabetes mellitus, n (%) 1 (0.3) 25 (0.5) 20 (0.5) 36 (0.8) 27 (1.0) 43 (1.7) 21 (3.6) <0.001
Antihypertensive medications, n (%) 6 (1.3) 83 (1.3) 94 (1.9) 159 (3.1) 138 (4.1) 155 (5.3) 50 (7.4) <0.001
Values are mean (SD) or number (percentage); the means (except age means) and percentages are adjusted for age using linear or logistic regression models, respectively. Because of
missing observations, numbers for the variables may be marginally less. BMI indicates body mass index; HDL, high-density lipoprotein.
DOI: 10.1161/JAHA.117.008414 Journal of the American Heart Association 5
Sex Differences in the Impact of BMI on New AF Ball et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 by guest on June 21, 2018
http://jaha.ahajournals.org/
D
ow
nloaded from
 
Table 2. Baseline Characteristics of 7158 Men According to BMI Change Groups: The Tromsø Study
Characteristics
10-y Change in BMI, kg/m2
P Value<1 1 to <0 0 to <1 1 to <2 2 to <3 ≥3
Participants, n 666 976 1548 1600 1118 1250
AF cases, n (%)* 62 (3.8) 80 (3.7) 128 (4.6) 128 (4.6) 85 (5.2) 92 (5.9) 0.036
Age, mean (SD), y
1986–1987 42.4 (11.3) 41.8 (10.7) 39.6 (10.3) 39.4 (10.2) 37.6 (10.0) 35.6 (10.3) <0.001
At AF diagnosis 39.5 (5.3) 41.1 (4.7) 40.7 (4.8) 40.8 (4.8) 40.4 (4.7) 39.9 (5.2) 0.298
BMI, mean (SD), kg/m2
1986–1987 25.9 (3.7) 24.8 (2.9) 24.5 (2.7) 24.6 (2.7) 24.7 (2.7) 25.1 (3.1) <0.001
1994–1995 23.7 (3.4) 23.9 (2.9) 24.5 (2.7) 25.4 (2.8) 26.3 (2.7) 28.0 (3.3) <0.001
Systolic blood pressure, mean (SD), mm Hg
1986–1987 134.8 (15.8) 133.4 (13.8) 132.6 (13.6) 132.8 (13.5) 132.8 (13.0) 133.9 (13.1) 0.003
1994–1995 130.0 (17.4) 131.1 (17.0) 130.9 (16.3) 132.5 (16.1) 133.2 (15.9) 134.9 (15.7) <0.001
Total cholesterol, mean (SD), mmol/L
1986–1987 6.10 (1.23) 6.08 (1.28) 5.97 (1.21) 5.96 (1.20) 5.96 (1.19) 5.96 (1.26) 0.005
1994–1995 5.65 (1.21) 5.79 (1.21) 5.84 (1.15) 5.96 (1.19) 6.07 (1.19) 6.21 (1.17) <0.001
HDL cholesterol, mean (SD), mmol/L
1986–1987 1.35 (0.33) 1.38 (0.35) 1.38 (0.32) 1.37 (0.32) 1.37 (0.35) 1.37 (0.33) 0.458
1994–1995 1.43 (0.39) 1.42 (0.39) 1.38 (0.35) 1.33 (0.34) 1.31 (0.33) 1.26 (0.31) <0.001
Triglycerides, mean (SD), mmol/L
1986–1987 1.77 (1.13) 1.65 (0.91) 1.59 (0.94) 1.61 (0.96) 1.62 (1.04) 1.62 (1.01) 0.003
1994–1995 1.36 (0.88) 1.50 (0.95) 1.56 (0.97) 1.78 (1.13) 1.96 (1.27) 2.24 (1.41) <0.001
Physical activity, n (%)
1986–1987
Inactive 177 (26.6) 202 (20.7) 295 (19.1) 338 (21.2) 222 (19.9) 292 (23.4) <0.001
Low activity 352 (52.7) 505 (51.8) 795 (52.1) 803 (51.0) 566 (52.0) 590 (49.2) 0.915
Moderate activity 116 (17.4) 240 (24.6) 387 (24.9) 397 (24.7) 280 (24.8) 306 (24.1) 0.009
High activity 21 (2.9) 29 (2.7) 70 (3.8) 61 (3.2) 50 (3.5) 62 (3.5) 0.710
1994–1995
Inactive 55 (8.3) 85 (8.8) 102 (6.6) 88 (5.5) 90 (8.1) 106 (8.6) 0.004
Low activity 261 (37.1) 338 (32.8) 593 (37.1) 675 (40.9) 477 (41.9) 586 (46.9) <0.001
Moderate activity 284 (43.8) 455 (47.8) 677 (44.7) 684 (43.5) 460 (41.8) 466 (37.8) 0.003
High activity 59 (11.4) 87 (11.3) 159 (12.0) 141 (10.2) 82 (8.0) 78 (6.2) <0.001
Current smoking, n (%)
1986–1987 310 (46.6) 441 (45.1) 674 (43.0) 662 (40.8) 493 (43.2) 607 (47.3) 0.007
1994–1995 345 (53.6) 425 (45.3) 633 (42.1) 582 (37.5) 370 (33.8) 349 (28.3) <0.001
History of myocardial infarction, n (%)*
New cases between surveys 18 (1.1) 17 (0.8) 28 (0.9) 28 (1.0) 16 (0.9) 27 (1.7) <0.001
History of angina pectoris, n (%)*
New cases between surveys 29 (1.4) 31 (1.1) 33 (1.1) 28 (0.8) 16 (0.9) 37 (1.9) <0.001
History of stroke, n (%)*
New cases between surveys 16 (1.3) 7 (0.5) 15 (0.7) 11 (0.5) 6 (0.5) 6 (0.5) 0.066
Continued
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CIs) to assess the impact of individual change in BMI over
10 years (slopes multiplied by 10) on the risk of future AF, with
AF as the dependent variable, fractional polynomials of BMI
change over 10 years as the main predictor, and fractional
polynomials of baseline BMI and fractional polynomials of
baseline age as covariates. An increase in BMI of 1 unit (1 kg/
m2) per 10 years was used as the reference. The model was
additionally adjusted for baseline values of systolic blood
pressure; total cholesterol, HDL cholesterol, and triglyceride
levels; current daily smoking; physical activity levels; CVD
(myocardial infarction, angina, and stroke); concurrent diabetes
mellitus; and current antihypertensivemedications. Aswith data
on the single measurement of BMI, sensitivity analyses were
conducted to investigate the impact of AF type on the
association of BMI change over 10 years on the future risk of AF.
Results
Baseline Characteristics
Table 1 demonstrates the baseline characteristics of the total
included cohort of 24 799 men and women who attended the
fourth Tromsø Study survey, according to BMI classiﬁcation
groups.26 Among men, the BMI groups differed with respect
to age, risk factors for CVD, history of CVD, and self-reported
antihypertensive medication use. Mean age differed across
the BMI groups, with underweight men being the oldest (mean
age, 50.917.7 years) and those with a BMI ≥35.00 kg/m2
being slightly younger (mean age, 46.413.5 years) than
those with a BMI between 27.50 and 34.99 kg/m2. Mean
systolic blood pressure and total cholesterol and triglyceride
levels all increased linearly with increasing BMI. HDL levels
decreased linearly as BMI increased. Men with a BMI up to
27.49 kg/m2 were more likely to report undertaking “mod-
erate” leisure time physical activity than those with a BMI
≥27.50 kg/m2, who were more likely to report undertaking
“low” physical activity. Underweight men were more likely to
report being a smoker (71.8%), with linearly decreasing
prevalence as BMI increased. The proportion of men reporting
a previous myocardial infarction increased with increasing
BMI. However, the highest proportion of individuals who had
experienced a previous stroke were in the underweight group
(2.2%). As expected, the proportion of men with diabetes
mellitus increased with increasing BMI, as did the proportion
of men who were prescribed antihypertensive medications.
In women, the patterns identiﬁed were the same as for
men. Similarly to the men, the age of women differed across
the BMI groups, with the highest mean age demonstrated in
obese class I (BMI, 30.00–34.99 kg/m2) individuals. Patterns
in blood pressure and cholesterol levels mirrored those
identiﬁed in the male cohort, as did patterns of physical
activity and smoking rates, with women in the underweight
group reporting the highest proportion of smokers (56.5%).
History of myocardial infarction was not signiﬁcantly different
between individuals in the different BMI groups. In contrast to
the male cohort, women with a BMI ≥35.00 kg/m2 reported
the highest rate of stroke (0.9%), although differences were
not signiﬁcantly different. The proportion of participants with
diabetes mellitus and those reporting antihypertensive med-
ication use increased linearly with increasing BMI. Tables 2
and 3 demonstrate the baseline proﬁle of men (n=7158) and
women (n=7494) included in the analyses of the impact of 10-
year change in BMI on the risk of future AF. Some patterns in
risk factors and incident CVD were similar in men and women,
with signiﬁcant differences demonstrated between the differ-
ent BMI change categories for most variables. However, men
demonstrated higher systolic blood pressure, lower HDL
levels, and higher triglyceride levels than women. Further-
more, men were more active than women and had more
incident cases of myocardial infarction and angina pectoris
between the 2 surveys than women.
Incidence of AF During Follow-Up
Over a mean follow-up of 15.75.5 years, 811 women (6.2%)
and 918 men (7.9%) from the fourth Tromsø Study survey
Table 2. Continued
Characteristics
10-y Change in BMI, kg/m2
P Value<1 1 to <0 0 to <1 1 to <2 2 to <3 ≥3
Diabetes mellitus, n (%)*
New cases between surveys 17 (1.2) 8 (0.4) 12 (0.5) 4 (0.1) 3 (0.2) 8 (0.5) <0.001
Antihypertensive medications, n (%)
1986–1987 36 (3.0) 17 (1.0) 38 (1.8) 47 (2.2) 18 (1.5) 21 (1.8) 0.010
1994–1995 58 (2.2) 45 (1.2) 68 (1.4) 97 (2.1) 44 (1.6) 68 (2.7) <0.001
Values are mean (SD) or number (percentage); the means (except age means) and percentages are adjusted for age between the surveys and 10-year BMI change groups using linear mixed
models or generalized estimating equations, respectively. AF indicates atrial ﬁbrillation; BMI, body mass index; HDL, high-density lipoprotein.
*Percentages are adjusted for age in 1986 to 1987 using a logistic regression model. Because of missing observations, numbers for the variables may be marginally less.
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Table 3. Baseline Characteristics of 7494 Women According to BMI Change Groups: The Tromsø Study
Characteristics
10-y Change in BMI, kg/m2
P Value<1 1 to <0 0 to <1 1 to <2 2 to <3 ≥3
Participants, n 708 773 1255 1450 1202 2106
AF cases, n (%)* 24 (1.8) 21 (1.4) 37 (1.5) 40 (1.5) 43 (2.1) 95 (2.8) 0.003
Age, mean (SD), y
1986–1987 36.4 (10.4) 37.5 (9.9) 37.6 (9.5) 37.2 (9.4) 37.3 (9.2) 36.7 (9.4) 0.021
At AF diagnosis 40.7 (4.6) 41.0 (3.8) 42.4 (4.6) 41.1 (4.7) 40.2 (5.2) 41.5 (4.7) 0.408
BMI, mean (SD), kg/m2
1986–1987 25.1 (4.0) 23.3 (3.1) 23.0 (3.0) 23.0 (3.0) 23.4 (3.1) 24.2 (3.7) <0.001
1994–1995 22.3 (3.6) 22.1 (3.1) 22.7 (3.0) 23.4 (3.0) 24.6 (3.1) 27.4 (4.3) <0.001
Systolic blood pressure, mean (SD), mm Hg
1986–1987 127.2 (15.6) 124.3 (13.7) 124.2 (13.9) 125.3 (14.2) 125.0 (14.7) 125.8 (14.2) <0.001
1994–1995 121.8 (18.3) 121.3 (17.1) 121.4 (16.9) 122.4 (17.2) 124.1 (18.1) 127.4 (18.3) <0.001
Total cholesterol, mean (SD), mmol/L
1986–1987 6.27 (1.30) 5.99 (1.27) 5.90 (1.28) 5.89 (1.22) 5.85 (1.17) 5.97 (1.23) <0.001
1994–1995 5.68 (1.29) 5.69 (1.31) 5.66 (1.29) 5.69 (1.25) 5.80 (1.27) 6.06 (1.28) <0.001
HDL cholesterol, mean (SD), mmol/L
1986–1987 1.67 (0.39) 1.70 (0.38) 1.69 (0.39) 1.68 (0.38) 1.68 (0.37) 1.65 (0.36) 0.006
1994–1995 1.68 (0.41) 1.70 (0.42) 1.69 (0.41) 1.64 (0.39) 1.63 (0.38) 1.56 (0.37) <0.001
Triglycerides, mean (SD), mmol/L
1986–1987 1.44 (0.84) 1.19 (0.69) 1.12 (0.58) 1.14 (0.59) 1.14 (0.59) 1.16 (0.58) <0.001
1994–1995 1.10 (0.67) 1.10 (0.71) 1.11 (0.70) 1.19 (0.79) 1.25 (0.78) 1.50 (0.92) <0.001
Physical activity, n (%)
1986–1987
Inactive 181 (26.2) 181 (23.9) 277 (22.6) 318 (22.4) 262 (22.3) 520 (25.3) 0.149
Low activity 462 (65.9) 509 (66.4) 841 (67.7) 972 (67.7) 832 (69.8) 1397 (67.0) 0.521
Moderate activity 59 (8.0) 77 (9.7) 118 (9.1) 142 (9.5) 96 (7.7) 175 (8.0) 0.328
High activity 6 (0.6) 6 (0.6) 16 (1.0) 16 (0.9) 12 (0.8) 14 (0.5) 0.348
1994–1995
Inactive 59 (8.3) 53 (6.8) 74 (5.8) 89 (6.1) 62 (5.1) 186 (8.8) <0.001
Low activity 288 (40.8) 326 (42.0) 555 (44.5) 632 (43.5) 548 (45.8) 1040 (49.7) <0.001
Moderate activity 317 (45.7) 349 (46.1) 550 (45.2) 652 (45.9) 543 (46.4) 801 (39.0) <0.001
High activity 37 (5.4) 40 (5.6) 56 (4.9) 67 (5.0) 34 (3.1) 53 (2.7) <0.001
Current smoking, n (%)
1986–1987 358 (47.4) 361 (44.1) 563 (42.4) 595 (38.4) 520 (40.6) 1008 (44.8) <0.001
1994–1995 382 (55.5) 362 (48.8) 555 (46.2) 544 (39.1) 438 (38.0) 724 (35.5) <0.001
History of myocardial infarction, n (%)*
New cases between surveys 6 (0.4) 2 (0.1) 4 (0.2) 7 (0.2) 2 (0.1) 8 (0.2) <0.001
History of angina pectoris, n (%)*
New cases between surveys 6 (0.3) 7 (0.3) 9 (0.2) 11 (0.2) 11 (0.4) 19 (0.4) 0.865
History of stroke, n (%)*
New cases between surveys 5 (0.5) 1 (0.2) 4 (0.3) 6 (0.3) 6 (0.4) 8 (0.4) <0.001
Continued
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developed AF (Table 4). For individuals who attended the third
and fourth Tromsø Study surveys and whose change in BMI
over 10 years was calculated, 3.5% of women (n=260) and
8.0% of men (n=575) developed AF during follow-up (Table 4).
Impact of Single-Measurement BMI on the Risk of
Future AF
Overall, in men, lower BMI was associated with a decreased
risk of future AF and higher BMI was associated with an
increased risk (Figure 2A). In comparison to men with a BMI
of 23.0 kg/m2 (reference), men with a BMI of 18.0 and
20.0 kg/m2 were at signiﬁcantly lower risk of developing AF
in the future (HR, 0.75 [95% CI, 0.70–0.81]; and HR, 0.84
[95% CI, 0.80–0.88], respectively). Men who just fell into the
overweight category with a BMI of 25.0 kg/m2 had a 14%
higher risk of incident AF than those with a BMI of 23.0 kg/
m2 at any time during follow-up. This risk increased signiﬁ-
cantly as BMI increased, and men who were classiﬁed as class
III obese (BMI, 40.0 kg/m2) were at almost a 4.5-fold higher
risk of incident AF than those at the reference BMI (23.0 kg/
m2) during follow-up. When results for men were stratiﬁed for
age (<65 years [5.1% of those who developed AF] versus ≥65
years [30.6% of those who developed AF]), the overall
patterns of association with single-measurement BMI and
future AF risk were similar; lower BMI was associated with a
decreased AF risk and increased BMI was associated with an
increased AF risk (data not shown). However, associations
were stronger for men aged <65 years compared with men
aged ≥65 years, with smaller HRs at lower BMIs and larger
HRs at higher BMIs. Men <65 years with a BMI of 20 kg/m2
had a 26% reduced risk of future AF (HR, 0.74; 95% CI, 0.68–
0.80), whereas men ≥65 years with a BMI of 20 kg/m2 only
had an 11% reduced risk (HR, 0.89; 95% CI, 0.80–0.98). At a
BMI of 40 kg/m2, men <65 years were at >5.5 times the risk
of future AF (HR, 5.59; 95% CI, 3.51–8.90), whereas men aged
≥65 years with the same BMI were at 2-fold risk of future AF
(HR, 1.97; 95% CI, 1.12–3.44).
Overall for women, a signiﬁcant relationship was found
between BMI and future AF (Figure 2B). A similar pattern was
demonstrated in women as for men, although associations for
higher BMIs were not as strong. BMIs of 18.0 and 20.0 kg/
m2 were associated with an 18% and 11% decreased risk of
future incident AF, respectively, compared with women at the
reference BMI (23.0 kg/m2). BMIs of ≥25.0 kg/m2 were
associated with a signiﬁcantly increased risk of incident AF at
any time during follow-up; those who were classiﬁed as class
III obese (BMI, 40.0 kg/m2) were at almost double the risk
(HR, 1.95; 95% CI, 1.48–2.56).
Sensitivity analyses
Potential mediating factors. Results of sensitivity analyses
testing different models of association in men and women
separately with and without potential mediating factors of the
relationship between BMI and incident AF are presented in
Table S1. Despite removal of potential mediating factors, such
as physical activity levels, current smoking, cholesterol levels,
prior CVD, concurrent diabetes mellitus, and antihypertensive
medication use, patterns of association were not markedly
different between the models and remained highly signiﬁcant
(all P<0.001).
Table 3. Continued
Characteristics
10-y Change in BMI, kg/m2
P Value<1 1 to <0 0 to <1 1 to <2 2 to <3 ≥3
Diabetes mellitus, n (%)*
New cases between surveys 8 (1.1) 1 (0.2) 6 (0.5) 3 (0.2) 5 (0.4) 13 (0.6) <0.001
Antihypertensive medications, n (%)
1986–1987 24 (3.3) 8 (0.9) 22 (1.6) 27 (1.8) 25 (2.1) 41 (2.1) 0.038
1994–1995 32 (1.7) 20 (0.9) 38 (1.1) 53 (1.4) 37 (1.2) 82 (1.6) 0.086
Values are mean (SD) or number (percentage); the means (except age means) and percentages are adjusted for age between the surveys and 10-year BMI change groups using linear mixed
models or generalized estimating equations, respectively. AF indicates atrial ﬁbrillation; BMI, body mass index; HDL, high-density lipoprotein.
*Percentages are adjusted for age in 1986 to 1987 using a logistic regression model. Because of missing observations, numbers for the variables may be marginally less.
Table 4. Incidence of AF During Follow-Up in Those With a
Single BMI Measurement (Fourth Tromsø Study Survey) and in
Those for Whom Change in BMI Over 10 Years Was
Calculated: The Tromsø Study
Sex
Single BMI Measurement
Individual 10-y Change in
BMI
No AF AF* No AF AF*
Men 10 755 918 (7.9) 6583 575 (8.0)
Women 12 315 811 (6.2) 7234 260 (3.5)
AF indicates atrial ﬁbrillation; BMI, body mass index.
*Data are given as number (percentage).
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AF type. Findings of sensitivity analyses stratifying results by
AF type (paroxysmal/persistent versus permanent) are pre-
sented in Table 5. For those with paroxysmal/persistent AF,
no signiﬁcant association between single-measurement BMI
and future AF was demonstrated (potentially because of lack
of study power). For individuals with permanent AF, clear and
signiﬁcant associations between reduced BMI and reduced
risk of future AF and between increased BMI and increased
risk of future AF were demonstrated. Patterns of association
were stronger in men than in women; a BMI of 40 kg/m2 was
signiﬁcantly associated with a 9-fold increased risk in men
and a 3-fold increased risk in women of future AF
development.
Impact of Individual 10-Year Change in BMI on
Risk of Future AF
Overall, in men, a decrease in BMI over 10 years was
associated with a decreased risk of future AF and an increase
in BMI was associated with an increased risk of AF
development during follow-up (Figure 3A). Maintenance of
BMI over time was similarly associated with a signiﬁcantly
decreased risk of future AF of 7%. For women, the patterns of
association for BMI change over time were similar to those
seen for men (Figure 3B). An increase in BMI over a 10 year
period of 3 or 4 kg/m2 was signiﬁcantly associated with an
increased AF risk of 15% (HR, 1.15; 95% CI, 1.04–1.26) and
23% (HR, 1.23; 95% CI, 1.07–1.41), respectively (Figure 3B).
Sensitivity analyses
AF type. Analyses of the association of change in BMI over
time with risk of future AF stratiﬁed by AF type are presented
in Table 6. For men with paroxysmal/persistent AF, mainte-
nance or a reduction in BMI over 10 years signiﬁcantly
reduced the risk of future AF, and increased BMI signiﬁcantly
increased the risk of future AF. The pattern was the same in
women, although signiﬁcance was not reached (P=0.058). For
those with permanent AF, maintenance or reduction in BMI
over 10 years signiﬁcantly reduced the risk of future AF and
an increase in BMI by ≥2 units signiﬁcantly increased the risk
of future AF in both men and women (P=0.005 and P=0.012,
respectively). HRs for men and women with permanent AF
were similar.
Discussion
In the present study, we expand the current body of
knowledge on the impact of BMI on risk of AF by analyzing
BMI change over time. Within a large population cohort, we
tested and conﬁrmed sex differences in the inﬂuence of BMI
on future risk of AF. In both men and women, higher BMI
(beyond that classiﬁed as “normal”) was signiﬁcantly and
independently associated with an increased risk of future AF,
and having a lower BMI conferred a decreased risk, during an
average follow-up of almost 16 years. These associations
were stronger in men; a BMI of 40.0 kg/m2 increased the risk
of future AF incidence by 4.5-fold in men compared with
almost 2-fold in women. In addition, associations were
stronger in men aged <65 years than in those aged ≥65
years. In both men and women, regardless of baseline
measurement, those who decreased or maintained their BMI
over a 10-year period decreased their risk of future AF. In
Figure 2. Inﬂuence of single-measurement body mass index
(BMI) on the risk of future atrial ﬁbrillation (AF) in men (A) and
women (B) in the Tromsø Study. HR indicates hazard ratio; LCL,
lower conﬁdence level; UCL, upper conﬁdence level.
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addition, those who increased their BMI by ≥2 kg/m2 over a
10-year period increased their risk of future AF. All results
were independent of age, baseline BMI (for change analyses
only), blood pressure, cholesterol levels, current smoking,
physical activity levels, history of CVD, concurrent diabetes
mellitus, and current antihypertensive medication use.
Removal of potential mediators of the relationship between
BMI and incident AF did not substantially change the models
and did not affect signiﬁcance. Stratiﬁcation of results by AF
type revealed that single-measurement BMI was not signiﬁ-
cantly associated with future AF risk in men and women with
paroxysmal/persistent AF. Lower BMI was associated
with reduced risk of future AF and higher BMI was associated
with increased risk of future AF in both men and women with
permanent AF, although associations were stronger in men
than in women. Change in BMI over time in those with
paroxysmal/persistent AF was signiﬁcantly associated
with future AF risk in men only, not women. For those with
permanent AF, change in BMI over time was signiﬁcantly
associated with future AF risk in both men and women, with
decreasing BMI associated with decreased AF risk and
increasing BMI associated with an increased future AF risk.
Overweight and obesity are well-established major CVD
risk factors,29 and previous population studies have demon-
strated that overweight and obesity are signiﬁcantly and
independently associated with increased AF
risk.9,12,13,17,18,30–35 Few studies have, however, assessed
the inﬂuence of BMI across the spectrum from underweight to
severely obese, and most focus only on obesity. Furthermore,
none have conducted statistical analyses using fractional
polynomials, which allows the comprehensive identiﬁcation of
patterns of association. Results of a meta-analysis of data
from 9 cohort studies and 14 case-control studies suggested
that there was a 19% to 29% excess risk of AF associated with
every 5 kg/m2 increase in BMI in the general population (odds
ratio, 1.29 [95% CI, 1.23–1.36]; and odds ratio, 1.19 [95% CI,
1.13–1.26], respectively).36 Only 3 of the included studies,
however, provided sex-speciﬁc estimates.36 Recent results
from a substudy of the Biomarcare Consortium involving data
from 4 community-based European studies (FINRISK [Finnish
National Risk Factor Survey], DanMONICA [Danish Monitoring
of Trends and Determinants in Cardiovascular Disease], Moli-
sani, and Northern Sweden), including data from 79 793
individuals, found that among the classic risk factors, BMI
explained the largest proportion of AF risk. Sex differences
were seen for risk associations of BMI (HR per SD increase
was 1.18 [95% CI, 1.12–1.23] in women versus 1.31 [95% CI,
1.25–1.38] in men; interaction P=0.001).37 Therefore, the
current study adds to the body of knowledge by comprehen-
sively determining sex differences in the impact of BMI on
future incident AF (including providing BMI-speciﬁc HRs) and
conﬁrms that associations between BMI and future develop-
ment of AF are signiﬁcant in both sexes but differ in size.
We analyzed data from a large sex-balanced population
sample with extensive and relatively recent mean follow-up of
almost 16 years. We also investigated the impact of BMI
across the spectrum from underweight to severely obese and
the impact of change in BMI over time. Our results suggest
that BMI has a sex-speciﬁc inﬂuence on the risk of future
incident AF; higher BMI potentially has a greater inﬂuence in
men than in women. These differences may be because of
differences in the cause and pathophysiological features of AF
that exist between the sexes.21,38 BMI asserts its effect on
the development of AF, partly through the development of
Table 5. Sensitivity Analyses Stratifying the Association of Single-Measurement BMI With the Risk of Future Development of AF by
AF Type
BMI, kg/m2
Paroxysmal/ Persistent AF Permanent AF
HR (95% CI) HR (95% CI)
Men Women Men Women
18 0.90 (0.77–1.06) 0.91 (0.81–1.03) 0.52 (0.45–0.61) 0.72 (0.64–0.81)
20 0.94 (0.86–1.03) 0.94 (0.88–1.02) 0.68 (0.62–0.74) 0.82 (0.77–0.88)
23 1.00 (Reference) 1.00 (Reference) 1.00 (Reference) 1.00 (Reference)
25 1.04 (0.98–1.11) 1.04 (0.99–1.09) 1.30 (1.22–1.37) 1.14 (1.09–1.19)
28 1.11 (0.95–1.29) 1.10 (0.98–1.24) 1.91 (1.65–2.22) 1.39 (1.24–1.56)
30 1.15 (0.93–1.44) 1.14 (0.97–1.35) 2.47 (2.01–3.05) 1.59 (1.35–1.86)
35 1.28 (0.88–1.89) 1.25 (0.94–1.67) 4.73 (3.31–6.75) 2.20 (1.68–2.90)
40 1.41 (0.83–2.40) 1.38 (0.92–2.07) 9.03 (5.45–14.95) 3.06 (2.08–4.51)
AF cases, n 452 387 407 342
P value 0.202 0.121 <0.001 <0.001
AF indicates atrial ﬁbrillation; BMI, body mass index; CI, conﬁdence interval; HR, hazard ratio.
DOI: 10.1161/JAHA.117.008414 Journal of the American Heart Association 11
Sex Differences in the Impact of BMI on New AF Ball et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 by guest on June 21, 2018
http://jaha.ahajournals.org/
D
ow
nloaded from
 
ﬁbrosis.39 Fibrosis resulting from higher BMI has previously
been demonstrated to be more severe in men than in
women.39 Our ﬁnding that decreasing BMI over time results in
a signiﬁcantly decreased risk of future AF development
supports the ﬁndings of others that structural and electrical
cardiac remodeling is reversible and reversibility can be
induced with aggressive risk factor modiﬁcation, including the
reduction of BMI in overweight or obese individuals.40
The ﬁndings of this study carry important clinical implica-
tions that differ for men and women. Although substantial
effort has been invested in identifying the associations of
overweight and obesity on AF development, little work has
been conducted on the beneﬁcial effect of weight reduction in
the primary prevention of AF. Berkovitch and colleagues did,
however, demonstrate that in a cohort of middle-aged adults
(mean age, 4911 years; 73% men) attending annual
screening at a tertiary medical center, during 64 years of
follow-up, each unit reduction in BMI was associated with a
signiﬁcant 7% reduction in the risk for the occurrence of a ﬁrst
AF event (HR, 0.93; 95% CI, 0.88–0.99; P=0.019).34 Further
understanding of sex-speciﬁc differences in the inﬂuence of
BMI on incident AF will assist in the primary prevention of this
disease and has the potential to contribute to more speciﬁc
and personalized (sex-speciﬁc) preventive strategies. Inter-
ventions to promote normal weight should be encouraged for
those at high risk, with even modest reductions in population
BMI likely to have a signiﬁcant effect on the public health
burden of AF.
Limitations
There exist some limitations of this study that require
comment. First, baseline data were collected via self-report,
which may have underestimated or overestimated the preva-
lence of smoking, level of physical activity, comorbidities, and
antihypertensive medication use within this cohort. Second,
detailed data on prescribed drug therapy and comorbidities,
which may or may not have inﬂuenced the future development
of AF or may have been more common in one sex over the
other (potentially having a protective or promoting effect on
AF development), were also not collected. Many changes in
prescribed medical therapies and comorbidities may have
occurred during follow-up that also could have inﬂuenced the
risk of incident AF. Third, we cannot be sure of changes in BMI
that took place within individuals during follow-up that may
have inﬂuenced (negatively or positively) the risk of future AF.
Fourth, we also cannot be sure whether the biomedical risk
factors and comorbidities considered in the analysis of single-
measurement BMI are potential mediators or confounders to
the relationship between BMI and future AF, although it is
likely that they are a combination of both and removal
revealed little change to the models of association identiﬁed.
Although BMI is a conventional measurement, it does not take
into account muscle mass and, therefore, some participants
may not actually have excess fat, although these individuals
would be expected to have lower incidence of AF. Further-
more, no data on body fat percentage or pericardial fat were
collected in the current study. We were also not able to
analyze the inﬂuence associations of BMI in symptomatic
versus asymptomatic AF because these data on symptoms
were not collected. Exclusion of participants with missing data
points reduced the sample size and may have resulted in the
loss of some cases of AF, although not many participants with
Figure 3. Inﬂuence of individual 10-year change in body mass
index (BMI) on the risk of future atrial ﬁbrillation (AF) in men (A)
and women (B) in the Tromsø Study. HR indicates hazard ratio;
LCL, lower conﬁdence level; UCL, upper conﬁdence level.
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missing data existed. There may also have been individuals
who developed AF but were not diagnosed during follow-up
(eg, those with silent asymptomatic AF). Finally, associations
were not adjusted for cardiorespiratory ﬁtness, which may
have inﬂuenced the risk of future AF development.
Conclusions
Within a large population cohort, higher BMI was signiﬁcantly
and independently associated with an increased risk of future
AF that was larger for men than women. Changes in BMI over
10 years inﬂuenced the risk of AF in both men and women.
Weight maintenance/reduction strategies should potentially
be different for women and men but should form part of a
lifetime approach to the primary prevention of AF for both
sexes. Future research is needed to conﬁrm our ﬁndings and
to understand the responsible mechanisms.
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SUPPLEMENTAL MATERIAL 
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Table S1. Models testing the influence of single measurement BMI on the risk of future AF in men and women in the Tromsø Study with progressive 
inclusion of potential mediators to the relationship. 
 Model 1* Model 2* Model 3 (presented)* 
MEN 
BMI (kg/m2) HR (95% CI) HR (95% CI) HR (95% CI) 
18 0.72 (0.68-0.77) 0.73 (0.68-0.78) 0.75 (0.70-0.81) 
20 0.81 (0.78-0.85) 0.82 (0.79-0.86) 0.84 (0.80-0.88) 
23 1.00 (reference) 1.00 (reference) 1.00 (reference) 
25 1.16 (1.13-1.20) 1.16 (1.12-1.19) 1.14 (1.10-1.18) 
28 1.50 (1.38-1.63) 1.47 (1.36-1.60) 1.42 (1.30-1.56) 
30 1.80 (1.60-2.03) 1.76 (1.56-1.98) 1.67 (1.46-1.92) 
35 3.02 (2.42-3.76) 2.88 (2.29-3.61) 2.63 (2.04-3.38) 
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40 5.47 (3.89-7.69) 5.09 (3.58-7.22) 4.42 (3.00-6.53) 
AF cases (n) 918 911 900 
p value <0.001 <0.001 <0.001 
WOMEN 
BMI (kg/m2) HR (95% CI) HR (95% CI) HR (95% CI) 
18 0.77 (0.72-0.83) 0.76 (0.71-0.82) 0.82 (0.76-0.89) 
20 0.86 (0.82-0.89) 0.85 (0.81-0.89) 0.89 (0.85-0.93) 
23 1.00 (reference) 1.00 (reference) 1.00 (reference) 
25 1.11 (1.08-1.14) 1.12 (1.08-1.15) 1.08 (1.05-1.12) 
28 1.30 (1.21-1.39) 1.31 (1.22-1.41) 1.22 (1.12-1.32) 
30 1.44 (1.30-1.59) 1.47 (1.32-1.63) 1.32 (1.18-1.47) 
35 1.87 (1.57-2.22) 1.93 (1.61-2.30) 1.60 (1.32-1.94) 
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40 2.42 (1.90-3.09) 2.53 (1.97-3.25) 1.95 (1.48-2.56) 
AF cases (n) 811 799 782 
p value <0.001 <0.001 <0.001 
 
BMI = body mass index; HR = hazard ratio; CI = confidence interval; AF = atrial fibrillation  
*Model 1: Cox regression with AF as the dependent variable, fractional polynomials of BMI as the main predictor and fractional polynomials of age as a 
covariate; Model 2: Model 1 with additional adjustment for current smoking and physical activity; Model 3 (presented model): Model 2 with additional 
adjustment for heart attack, angina, stroke, diabetes, systolic blood pressure, total cholesterol, HDL cholesterol, triglycerides and antihypertensive medication. 
 
 by guest on June 21, 2018
http://jaha.ahajournals.org/
D
ow
nloaded from
 
Morseth, Ellisiv B. Mathiesen, Inger Njølstad, Sweta Tiwari and Ekaterina Sharashova
Jocasta Ball, Maja-Lisa Løchen, Tom Wilsgaard, Henrik Schirmer, Laila A. Hopstock, Bente
Based Tromsø Study−Insights From the Longitudinal Population
 Sex Differences in the Impact of Body Mass Index on the Risk of Future Atrial Fibrillation:
Online ISSN: 2047-9980 
Dallas, TX 75231
 is published by the American Heart Association, 7272 Greenville Avenue,Journal of the American Heart AssociationThe 
doi: 10.1161/JAHA.117.008414
2018;7:e008414; originally published April 19, 2018;J Am Heart Assoc. 
 http://jaha.ahajournals.org/content/7/9/e008414
World Wide Web at: 
The online version of this article, along with updated information and services, is located on the
 
 for more information. http://jaha.ahajournals.orgAccess publication. Visit the Journal at 
 is an online only OpenJournal of the American Heart AssociationSubscriptions, Permissions, and Reprints: The 
 by guest on June 21, 2018
http://jaha.ahajournals.org/
D
ow
nloaded from
 
